Phathom Pharmaceuticals, Inc.
PHAT • NASDAQ • Stock Fundamentals
Phathom Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Steven L. Basta, with a market cap of $819.1M.
Market Cap$819.1M
Employees112.0
CEOSteven L. Basta
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsApr 30, 2026 · 1 month 15 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Phathom Pharmaceuticals, Inc. FAQ
Common questions about Phathom Pharmaceuticals, Inc.
Phathom Pharmaceuticals, Inc. (PHAT) has a market capitalization of $819.1M and trades on NASDAQ.
Phathom Pharmaceuticals, Inc. has approximately 112 employees.